Results vary, but most patients lose an average of 1015 pounds within the first two months, depending on dosage, metabolism, and commitment to healthy lifestyle habits
This size theoretically limits intestinal absorption in infants, but limited real-world lactation studies exist for semaglutide, tirzepatide, and other GLP-1 drugs
But as Noom points out, it appears that most people taking these new medications, whether or not they use a weight-loss company to prescribe them, are eventually going off their medications, whether it's because of the expense, shortages, side effects, or an aversion to the idea of staying on a medicine perpetually
Some people also report that MIC B12 injections have helped with sleep, memory, and concentration
So, weight loss helps reduce insulin resistance
5 Figure 1: Effect of once-weekly tirzepatide, compared with semaglutide, on lipid profile 5 GLP-1s are also being investigated for the prevention and treatment of heart failure